Interaction of flaviviruses with cells of the vertebrate host and decoy of the immune response

Immunology and Cell Biology

Volumn 81, Issue 3, 2003, Pages 207-216

  King, Nicholas J C ^a   Kesson, Alison M ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Cell adhesion molecules; Flavivirus; Langerhans cells; Major histocompatibility complex; T lymphocytes; West Nile virus

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VIRUS ANTIGEN; VIRUS VACCINE;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIVIRAL ACTIVITY; ARTICLE; AUTOIMMUNITY; BINDING AFFINITY; CELL CYCLE; CELL MIGRATION; CELL SPECIFICITY; CELL SURFACE; CROSS REACTION; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DISEASE EXACERBATION; DISEASE MODEL; ENDEMIC DISEASE; EPIDEMIC; EPIDEMIC ENCEPHALITIS; FATALITY; FLAVIVIRUS; GENE; HUMAN; HYPOTHESIS; ICAM1 GENE; IMMUNE ADHERENCE; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; INFLAMMATION; INTERFERON PRODUCTION; LANGERHANS CELL; LYMPHATIC DRAINAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MHC GENE; MORBIDITY; MORTALITY; NONHUMAN; REGULATORY MECHANISM; SIDE EFFECT; SKIN INFECTION; TRANSCRIPTION REGULATION; VERTEBRATE; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS ENCEPHALITIS;

ANIMALS; AUTOIMMUNITY; CELL ADHESION MOLECULES; FLAVIVIRUS; FLAVIVIRUS INFECTIONS; HUMANS; INSECT VIRUSES; MAJOR HISTOCOMPATIBILITY COMPLEX; T-LYMPHOCYTES; UP-REGULATION;

ANIMALIA; FLAVIVIRUS; JAPANESE ENCEPHALITIS VIRUS; MURINAE; RNA VIRUSES; VERTEBRATA; WEST NILE VIRUS;

EID: 0038018172     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.2003.01167.x     Document Type: Article

References (76)

1. Burke DS, Monath TP. Flaviviruses. In: Knipe DM, Howley PM, eds. Fields Virology 4th edn. Philadelphia, PA, USA: Lippincott, Williams & Wilkins 2001; 1043-145.
2. McCullough D. The Path Between the Seas: the Creation of the Panama Canal. New York, NY, USA: Simon and Schuster, 1977.
3. Anderson JF, Andreadis TG, Vossbrinck CR et al. Isolation of West Nile virus from mosquitoes, crows, and a Cooper's hawk in Connecticut. Science 1999; 286: 2331-3.
4. Briese T, Jia XY, Huang C, Grady LJ, Lipkin WI. Identification of a Kunjin/West Nile-like flavivirus in brains of patients with New York encephalitis. Lancet 1999; 354: 1261-2.
5. Lanciotti RS, Roehrig JT, Deubel V et al. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 1999; 286: 2333-7.
6. Hannah J, Ritchie S, Loewenthal M et al. Probable Japanese encephalitis acquired in the Torres Strait. Commun. Dis. Intell. 1995; 19: 206-8.
7. Gubler DJ. The global emergence/resurgence of arboviral diseases as public health problems. Arch. Med. Res. 2002; 33: 330-42.
8. Hubalek Z, Halouzka J. West Nile fever - a reemerging mosquito-borne viral disease in Europe. Emerg. Infect. Dis. 1999; 5: 643-50.
9. Monath TP, Soike K, Levenbook I et al. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates. Vaccine 1999; 17: 1869-82.
10. Arroyo J, Miller CA, Catalan J, Monath TP. Yellow fever vector live-virus vaccines: West Nile virus vaccine development. Trends Mol. Biol. 2001; 7: 350-4.
11. Lalani AS, Barrett JW, McFadden G. Modulating chemokines: more lessons from viruses. Immunol. Today 2000; 21: 100-6.
12. McFadden G, Murphy PM. Host-related immunomodulators encoded by poxviruses and herpesviruses. Curr. Opin. Microbiol. 2000; 3: 371-8.
13. Nash P, Barrett J, Cao JX et al. Immunomodulation by viruses: the myxoma virus story. Immunol. Rev. 1999; 168: 103-20.
14. Murphy PM. Viral exploitation and subversion of the immune system through chemokine mimicry. Nat. Immunol. 2001; 2: 116-22.
15. Scalzo AA. Successful control of viruses by NK cells - a balance of opposing forces? Trends Microbiol. 2002; 10: 470-4.
16. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-34.
17. Kuhlman P, Moy VT, Lollo BA, Brian AA. The accessory function of murine intercellular adhesion molecule-1 in T lymphocyte activation. Contributions of adhesion and coactivation. J. Immunol. 1991; 146: 1773-82.
18. Mattei F, Schiavoni G, Belardelli F, Tough DF. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J. Immunol. 2001; 167: 1179-87.
19. Le Bon A, Schiavoni G, D'Agostino G, Gresser I, Belardelli F, Tough DF. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 2001; 14: 461-70.
20. Tough DF, Borrow P, Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 1996; 272: 1947-50.
21. O'Neill HC, Blanden RV. Quantitative differences in the expression of parentally-derived H-2 antigens in F 1 hybrid mice affect T-cell responses. J. Exp. Med. 1979; 149: 724-31.
22. Goldstein SAN, Mescher MF. Cytotoxic T cell activation by class I protein on cell-size artificial membranes: antigen density and Lyt-2/3 function. J. Immunol. 1987; 138: 2034-43.
23. King NJ, Mullbacher A, Blanden RV. Relationship between surface H-2 concentration, size of different target cells, and lysis by cytotoxic T cells. Cell. Immunol. 1986; 98: 525-32.
24. Shimonkevitz R, Luescher B, Cerottini JC, MacDonald HR. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function. J. Immunol. 1985; 135: 892-9.
25. Tian L, Catt JW, O'Neill C, King NJ. Expression of immunoglobulin superfamily cell adhesion molecules on murine embryonic stem cells. Biol. Reprod. 1997; 57: 561-8.
26. King NJC, Sinickas VG, Blanden RV. H-2K and H-2D antigens are independently regulated in mouse embryo fibroblasts. Exp. Clin. Immunogenet. 1985; 2: 206-14.
27. Douglas MW, Kesson AM, King NJC. CTL recognition of West Nile virus-infected fibroblasts is cell cycle dependent and is associated with virus-induced increases in class I MHC antigen expression. Immunology 1994; 82: 561-70.
28. King NJC, Mullbacher A, Tian L, Rodger JC, Lidbury B, Hla RT. West Nile virus infection induces susceptibility of in vitro outgrown murine blastocysts to specific lysis by paternally directed allo-immune and virus-immune cytotoxic T cells. J. Reprod. Immunol. 1993; 23: 131-44.
29. Kesson AM, Cheng Y, King NJC. Regulation of immune recognition molecules by flavivirus, West Nile. Viral Immunol. 2002; 15: 273-83.
30. Mullbacher A, Blanden RV. H-2-linked control of cytotoxic T-cell responsiveness to alphavirus infection. Presence of H-2Dk during differentiation and stimulation converts stem cells of low responder genotype to T cells of responder phenotype. J. Exp. Med. 1979; 149: 786-90.
31. Yewdell J, Bennink J. Mechanism of viral interference with MHC class I antigen processing and presentation. Annu. Rev. Cell Dev. Biol. 1999; 15: 579-606.
32. Koszinowski U, Ertl H. Altered serological and cellular reactivity to H-2 antigens after target cell infection with vaccinia virus. Nature 1975; 257: 596-7.
33. Vossen MT, Westerhout EM, Soderberg-Naucler C, Wiertz EJ. Viral immune evasion: a masterpiece of evolution. Immunogenetics 2002; 54: 527-42.
34. Pääbo S, Weber F, Nilsson T, Schaffner W, Peterson PA. Structural and functional dissection of an MHC class I antigen-binding adenovirus glycoprotein. EMBO J. 1986; 5: 1921-7.
35. Pääbo S, Nilsson T, Peterson PA. Adenoviruses of subgenera B, C, D, and E modulate cell-surface expression of major histocompatibility complex class I antigens. Proc. Natl Acad. Sci. USA 1986; 83: 9665-9.
36. Brinton MA. The molecular biology of West Nile Virus: a new invader of the western hemisphere. Annu. Rev. Microbiol. 2002; 56: 371-402.
37. Argall KG, Armati PJ, King NJC, Douglas MW. The effects of West Nile virus on major histocompatibility complex class I and II molecule expression by Lewis rat Schwann cells in vitro. J. Neuroimmunol. 1991; 35: 273-84.
38. Bao S, King NJC, Dos Remedios CG. Flavivirus induces MHC antigen on human myoblasts: a model of autoimmune myositis? Muscle Nerve 1992; 15: 1271-7.
39. Johnston LJ, Halliday GM, King NJC. Phenotypic changes in Langerhans cells after infection with arboviruses: a role in the immune response to epidermally acquired viral infection? J. Virol. 1996; 70: 4761-6.
40. King NJ, Kesson AM. Interferon-independent increases in class I major histocompatibility complex antigen expression follow flavivirus infection. J. Gen. Virol. 1988; 69: 2535-43.
41. King NJC, Maxwell LE, Kesson AM. Induction of class I major histocompatibility complex antigen expression by West Nile virus on gamma interferon-refractory early murine trophoblast cells. Proc. Natl Acad. Sci. USA 1989; 86: 911-15.
42. Shen J, Devery JM, King NJC. Early induction of interferon-independent virus-specific ICAM-1 (CD54) expression by flavivirus in quiescent but not proliferating fibroblasts - implications for virus-host interactions. Virology 1995; 208: 437-49.
43. Shen J, Devery JM, King NJC. Adherence status regulates the primary cellular activation responses to the flavivirus West Nile. Immunology 1995; 84: 254-64.
44. Shen J, T-To SS, Schrieber L, King NJC. Early E-selectin, VCAM-1, ICAM-1, and late major histocompatibility complex antigen induction on human endothelial cells by flavivirus and comodulation of adhesion molecule expression by immune cytokines. J. Virol. 1997; 71: 9323-32.
45. + T-cell-mediated autoimmunity. Immunol. Rev. 1996; 152: 5-19.
46. Liu Y, King NJC, Kesson A, Blanden RV, Mullbacher A. Flavivirus infection up-regulates the expression of class I and class II major histocompatibility antigens on and enhances T cell recognition of astrocytes in vitro. J. Neuroimmunol. 1989; 21: 157-68.
47. Kesson AM, King NJC. Transcriptional regulation of major histocompatibility complex class I by flavivirus West Nile is dependent on NF-kappaB activation. J. Infect. Dis. 2001; 184: 947-54.
48. Karupiah G, Hunt NH, King NJC, Chaudhri G. NADPH oxidase, Nramp1 and nitric oxide synthase 2 in the host antimicrobial response. Rev. Immunogenet. 2000; 2: 387-415.
49. Mullbacher A, Lobigs M. Up-regulation of MHC class I by flavivirus-induced peptide translocation into the endoplasmic reticulum. Immunity 1995; 3: 207-14.
50. Baldwin AS Jr. The NF-kappa B and 1 kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 1996; 14: 649-83.
51. Jakob T, Udey MC. Regulation of E-cadherin-mediated adhesion in Langerhans cell-like dendritic cells by inflammatory mediators that mobilize Langerhans cells in vivo. J. Immunol. 1998; 160: 4067-73.
52. Kimber I, Dearman RJ, Cumberbatch M, Huby RJD. Langerhans cells and chemical allergy. Curr. Opin. Immunol. 1998; 10: 614-19.
53. Johnston LJ, Halliday GM, King NJC. Langerhans cells migrate to local lymph nodes following cutaneous infection with an arbovirus. J. Invest. Dermatol. 2000; 114: 560-8.
54. Byrne SN, Halliday GM, Johnston LJ, King NJC. Interleukin-1beta but not tumor necrosis factor is involved in West Nile virus-induced Langerhans cell migration from the skin in C57BL/6 mice. J. Invest. Dermatol. 2001; 117: 702-9.
55. Cumberbatch M, Dearman RJ, Kimber I. Langerhans cells require signals from both Tumour Necrosis Factor-alpha and Interleukin-1-beta for migration. Immunology 1997; 92: 388-95.
56. Huang S, Hendriks W, Althage A et al. Immune response in mice that lack the interferon-gamma receptor. Science 1993; 259: 1742-5.
57. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993; 259: 1739-42.
58. Sampson BA, Ambrosi C, Charlot A, Reiber K, Veress JF, Armbrustmacher V. The pathology of human West Nile Virus infection. Hum. Pathol. 2000; 31: 527-31.
59. Liu T, Chambers TJ. Yellow Fever Virus Encephalitis: Properties of the Brain-Associated T-Cell Response during Virus Clearance in Normal and Gamma Interferon-Deficient Mice and Requirement for CD4 (+) Lymphocytes. J. Virol. 2001; 75: 2107-18.
60. Liu MT, Chen BP, Oertel P et al. The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J. Immunol. 2000; 165: 2327-30.
61. Liu MT, Armstrong D, Hamilton TA, Lane TE. Expression of Mig (Monokine Induced by Interferon-gamma) Is Important in T Lymphocyte Recruitment and Host Defense Following Viral Infection of the Central Nervous System. J. Immunol. 2001; 166: 1790-5.
62. Andrews DM, Matthews VB, Sammels LM, Carrello AC, McMinn PC. The severity of Murray Valley encephalitis in mice is linked to neutrophil infiltration and inducible nitric oxide synthase activity in the central nervous system. J. Virol. 1999; 73: 8781-90.
63. Komar N, Langevin S, Hinten S et al. Experimental infection of north american birds with the New York 1999 strain of West Nile virus. Emerg. Infect. Dis. 2003; 9: 311-22.
64. Momburg F, Mullbacher A, Lobigs M. Modulation of transporter associated with antigen processing (TAP)-mediated peptide import into the endoplasmic reticulum by flavivirus infection. J. Virol. 2001; 75: 5663-71.
65. Diamond MS. Evasion of innate and adaptive immunity by flaviviruses. Immunol. Cell Biol. 2003; 81: 196-206.
66. Nahill SR, Welsh RM. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response. J. Exp. Med. 1993; 177: 317-27.
67. Selin LK, Nahill SR, Welsh RM. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J. Exp. Med. 1994; 179: 1933-43.
68. Zarozinski CC, Welsh RM. Minimal bystander activation of CD8 T cells during the virus-induced polyclonal T cell response. J. Exp. Med. 1997; 185: 1629-39.
69. Mullbacher A, Hill AB, Blanden RV, Cowden WB, King NJC, Hla RT. Alloreactive cytotoxic T cells recognize MHC class I antigen without peptide specificity. J. Immunol. 1991; 147: 1765-72.
70. Murray N, McMichael A. Antigen presentation in virus infection. Curr. Opin. Immunol. 1992; 4: 401-7.
71. Hill AB, Blanden RV, Parish CR, Müllbacher A. Restimulated memory Tc cells have a higher apparent avidity of interaction with targets than primary virus-immune Tc cells as indicated by anti-CD8 blocking. Immunol. Cell Biol. 1992; 70: 259-65.
72. Domingo E, Escarmis C, Sevilla N et al. Basic concepts in RNA virus evolution. FASEB J. 1996; 10: 859-64.
73. Freeman AJ, Marinos G, Ffrench RA, Lloyd AR. Immunopathogenesis of hepatitis C virus infection. Immunol. Cell Biol. 2001; 79: 515-36.
74. Lee LM, Henderson DK. Emerging viral infections. Curr. Opin. Infect. Dis. 2001; 14: 467-80.
75. Derby MA, Alexander-Miller MA, Tse R, Berzofsky JA. High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL. J. Immunol. 2001; 166: 1690-7.
76. Doherty PC, Hou S, Evans CF, Whitton JL, Oldstone MB, Blackman MA. Limiting the available T cell receptor repertoire modifies acute lymphocytic choriomeningitis virus-induced immunopathology. J. Neuroimmunol. 1994; 51: 147-52.